# Star Technology and Research (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/star-technology-and-research-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 56.3 |
| Citations | 38,645 |
| City | Mt. Pleasant |
| Country | US |
| Description | Star Technology and Research (United States) is a research organisation in Mt. Pleasant, US. OpenAlex records 1,737 works and 38,645 citations for it. 1,071 researchers list it as their most recent affiliation. |
| Homepage | http://www.star-tech-inc.com/ |
| OpenAlex ID | https://openalex.org/I4210088309 |
| Region | South Carolina |
| Researchers | 1,071 |
| ROR ID | https://ror.org/007c5ag63 |
| Type | company |
| Works | 1,737 |

## University papers

Showing 12 of 22.

- [Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy](https://scholariq.org/papers/increased-survival-with-enzalutamide-in-prostate-cancer-after-chemotherapy/)
- [Olaparib for Metastatic Castration-Resistant Prostate Cancer](https://scholariq.org/papers/olaparib-for-metastatic-castration-resistant-prostate-cancer/)
- [Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study](https://scholariq.org/papers/denosumab-versus-zoledronic-acid-for-treatment-of-bone-metastases-in-men-with/)
- [Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer](https://scholariq.org/papers/survival-with-olaparib-in-metastatic-castration-resistant-prostate-cancer/)
- [Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial](https://scholariq.org/papers/talazoparib-plus-enzalutamide-in-men-with-first-line-metastatic-castration/)
- [Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-avacincaptad-pegol-in-patients-with-geographic-atrophy/)
- [Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort](https://scholariq.org/papers/nivolumab-monotherapy-and-nivolumab-plus-ipilimumab-in-recurrent-small-cell-lung/)
- [Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer](https://scholariq.org/papers/improved-outcomes-with-enzalutamide-in-biochemically-recurrent-prostate-cancer/)
- [Extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a registry study](https://scholariq.org/papers/extracorporeal-cardiopulmonary-resuscitation-in-out-of-hospital-cardiac-arrest-a/)
- [Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial](https://scholariq.org/papers/ramucirumab-plus-pembrolizumab-in-patients-with-previously-treated-advanced-non/)
- [Risk factors for peritonitis in long-term peritoneal dialysis: The Network 9 peritonitis and catheter survival studies](https://scholariq.org/papers/risk-factors-for-peritonitis-in-long-term-peritoneal-dialysis-the-network-9/)
- [Mycophenolate Mofetil in Children with Frequently Relapsing Nephrotic Syndrome](https://scholariq.org/papers/mycophenolate-mofetil-in-children-with-frequently-relapsing-nephrotic-syndrome/)

## University researchers

- [Martin Bunke](https://scholariq.org/researchers/martin-bunke/)

## University top topics

Showing 8 of 22.

- [Advanced Fiber Optic Sensors](https://scholariq.org/topics/advanced-fiber-optic-sensors/)
- [Calcium Carbonate Crystallization and Inhibition](https://scholariq.org/topics/calcium-carbonate-crystallization-and-inhibition/)
- [Clay minerals and soil interactions](https://scholariq.org/topics/clay-minerals-and-soil-interactions/)
- [Photonic and Optical Devices](https://scholariq.org/topics/photonic-and-optical-devices/)
- [Space Satellite Systems and Control](https://scholariq.org/topics/space-satellite-systems-and-control/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Astrophysics and Cosmic Phenomena](https://scholariq.org/topics/astrophysics-and-cosmic-phenomena/)
- [Meteorological Phenomena and Simulations](https://scholariq.org/topics/meteorological-phenomena-and-simulations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.